Health

What do you usually do before you go to bed? If you're always watching TV or staring at your computer or phone for long periods of time, then the following research paper, just published online in Nature-Neuroscience, might give you some health reminders.

Eli Lilly announced today that its Phase 1 study of the primary antibody LY-CoV555, developed in collaboration with AbCellera, has been administered to the first patients.

Patients in the 5-day remdesivir treatment group were 65 percent more likely to have clinical improvement at Day 11 compared with those in the standard of care group, according to Gilead Sciences's phase 3 trial of Remdesivir in patients with moderate Covid-19.

China is among the first in the world in terms of vaccine development, with five vaccines currently in Phase II clinical trials.

A new study from Europe suggests that coronavirus immunity may last from six to 12 months.

The team of Bai Jingwei, Li Yinqing and Liu Peng of Tsinghua University has jointly developed an all-in-one self-service SARS-CoV-2 nucleic acid detection cartridge, which can be tested within 30 minutes.

There is currently no drug to cure the new coronavirus, but scientists have found more evidence that the human immune system can develop neutralizing antibodies that can block virus-infected cells.

A team led by Chinese scientists has identified two novel coronavirus-neutralizing antibodies with high specificity from survivors of novel coronavirus pneumonia disease, and demonstrated the therapeutic and preventive potential of one of the neutralizing antibodies in a rhesus monkey model.

China's research team has once again taken an important step forward in the development of a new coronavirus vaccine.

Li Wei, director of BYD's President's Office and secretary-general of the BYD Charity Foundation, said yesterday that at present, BYD's daily production of masks reaches 50 million, according to Shenzhen Business Daily.